ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "fibromyalgia"

  • Abstract Number: 158 • 2017 ACR/ARHP Annual Meeting

    Is Lu Eight-Brocades Exercise Beneficial for Patients with Fibromyalgia?

    Juan Jiao1, Irwin Jon Russell2, Wen Wang3, Ya-yun Zhao4, Rou-man Zhang4, Jing Wang4 and Quan Jiang5, 1Rheumatism Department, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China, 2Affiliated with Arthritis & Osteoporosis Center of South Texas, Medical Director, Fibromyalgia Research and Consulting, San Antonio, Texas, San Antonio, TX, 3JCW Education Consulting, Conway, AR, 4Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China, 5Rheumatology Department, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China

    Background/Purpose: Fibromyalgia is a chronic debilitating musculoskeletal pain syndrome that causes substantial physical and psychological impairments. With the release of the 2016 revised EULAR recommendations…
  • Abstract Number: 1991 • 2017 ACR/ARHP Annual Meeting

    Fibromyalgia in Russian Refugees: Translation and Validation of the Revised Symptom Impact Questionnaire

    Kim Jones1, Robert M. Bennett1, Ronald Friend2 and Neema Mohammad Nader2, 1Schools of Nursing and Medicine, Oregon Health & Science University, Portland, OR, 2School of Nursing, Oregon Health & Science University, Portland, OR

    Background/Purpose: The Revised Symptom Impact Questionnaire (SIQR) is an updated version of the Revised Fibromyalgia Impact Questionnaire (FIQR) that can be used in both fibromyalgia…
  • Abstract Number: 160 • 2017 ACR/ARHP Annual Meeting

    Fibromyalgia Screening Form in the Diagnosis of Concomitant Fibromyalgia

    Robert S. Katz1 and Jessica L. Polyak2, 1Rush University Medical Center, Chicago, IL, 2Rheumatology Associates S.C., Chicago, IL

    Background/Purpose: We have found that patients with a variety of rheumatic diseases who have concomitant fibromyalgia more frequently fail therapies for the underlying inflammatory rheumatic…
  • Abstract Number: 2115 • 2017 ACR/ARHP Annual Meeting

    Mast Cell Activation Features in Ehlers-Danlos/Joint Hypermobility Patients: A Retrospective Analysis in Light of an Emerging Disease Cluster

    Dave Lee1 and Eric Mueller2, 1Arthritis Northwest, PLLC, Spokane, WA, 2Discus Analytics LLC., Spokane, WA

    Background/Purpose: Mast cells are immune cells often residing in connective tissue, best known for their role in allergic and anaphylactic responses1. Mast cell activation syndrome…
  • Abstract Number: 843 • 2017 ACR/ARHP Annual Meeting

    The Role of Personality in Patients with Fibromyalgia

    Andrew Seto1, Teresa Wu1, Lori Lyn Price2,3,4,5, Xingyi Han6, William F. Harvey1 and Chenchen Wang7, 1Tufts Medical Center, Boston, MA, 2Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, 3Clinical Care Research, Tufts Medical Center, Boston, MA, 4Biostatistics Research Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, 5Tufts Clinical and Translational Science Institute, Tufts University, Boston, MA, 6Public Health and Community Medicine, Tufts University, Boston, MA, 7Rheumatology, Tufts Medical Center, Boston, MA

    Background/Purpose: Previous studies investigating the potential associations between personality and clinical symptoms in fibromyalgia (FM) patients have found mixed results. The purpose of this study…
  • Abstract Number: 2247 • 2017 ACR/ARHP Annual Meeting

    Secondary Fibromyalgia Is Not Associated with Higher Likelihood of Patient-Physician Discordance in Global Assessment in Patients with Osteoarthritis and Rheumatoid Arthritis

    Isabel Castrejón, Shakeel M. Jamal and Najia Shakoor, Division of Rheumatology, Rush University Medical Center, Chicago, IL

    Background/Purpose: Pain is the strongest driver of patient-physician discordance in global assessment in patients with rheumatoid arthritis (RA) and osteoarthritis (OA). Having secondary fibromyalgia (FM),…
  • Abstract Number: 1058 • 2016 ACR/ARHP Annual Meeting

    Adjustment Profiles Comprising Objective and Subjective Measures in Fibromyalgia Patients

    Fernando Estévez-López1,2, Inmaculada C Álvarez Gallardo1, Víctor Segura-Jiménez1,3, Milkana Borges-Cosic1, Manuel Pulido-Martos4, Ana Carbonell-Baeza3, Virginia A Aparicio1,5, Rinie Geenen2 and Manuel Delgado-Fernández1, 1University of Granada, Granada, Spain, 2Utrecht University, Utrecht, Netherlands, 3University of Cádiz, Cádiz, Spain, 4University of Jaén, Jaén, Spain, 5VU University Medical Care, Amsterdam, Netherlands

    Background/Purpose: Only one-third of FM patients obtain benefits after receiving one of the available therapy modalities. Insights into the heterogeneous picture of FM might improve…
  • Abstract Number: 1411 • 2016 ACR/ARHP Annual Meeting

    An Electronic MDHAQ (multidimensional health assessment questionnaire) Beyond an Electronic RAPID (routine assessment of patient index data): 21.3% of Rheumatoid Arthritis Patients Identified As Having Secondary Fibromyalgia Versus 3.5% By Clinicians

    Theodore Pincus and Nathaniel Cook, Rheumatology, Rush University Medical Center, Chicago, IL

    Background/Purpose: A major impediment to use of patient questionnaires in routine clinical care has been the absence of electronic entry for patients and for doctors…
  • Abstract Number: 1767 • 2016 ACR/ARHP Annual Meeting

    Poor Body Image in Lupus: Is It Disease Activity, Damage, Sleep, Pain, Fatigue, Stress, Function, Medications, Depression or Fibromyalgia?

    Stacy Weinberg1, Nisarg Gandhi2, Meenakshi Jolly3, Winston Sequeira2 and Shilpa Arora2, 1Rush University Medical Center, Chicago, IL, 2Rheumatology, Rush University Medical Center, Chicago, IL, 3Rush, Chicago, IL

    Background/Purpose: Patients with systemic lupus erythematosus (SLE) have poorer body image (BI) than age matched controls. Few studies have been done looking at the effect…
  • Abstract Number: 1791 • 2016 ACR/ARHP Annual Meeting

    Loss of Elbow Hyperextension in Females with Early Rheumatologic Disease Was Common in Systemic Lupus Erythematosus and Rheumatoid Arthritis but Rare in Fibromyalgia

    John P. Case1, Heidi Tucker2 and Congbin Wang3, 1Internal Medicine/Rheumatology, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL, 2Rush Medical College, Chicago, IL, 3Internal medicine, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL

    Background/Purpose:   The elbow extension angle (ELB) is commonly given as 180o although most healthy females exhibit hyperextension(1).  The loss of hyperextension (LOH) in a…
  • Abstract Number: 2080 • 2016 ACR/ARHP Annual Meeting

    Three Simple Tests to Raise the Index of Suspicion for Fibromyalgia in Primary Care

    Amanda W. St. John1, Jonathan H. Aebischer2, Robert M. Bennett3, Madeleine J. Sanford2, Kaitlin Z. Haws4 and Kim D. Jones3, 1Anesthesiology and Pain Medicine, Oregon Health & Science University, Portland, OR, 2Department of Family Medicine, Oregon Health & Science University, Portland, OR, 3Schools of Nursing and Medicine, Oregon Health & Science University, Portland, OR, 4Department of Internal Medicine and Geriatrics, Oregon Health & Science University, Portland, OR

    Background/Purpose:    356 patients were studied (mean age 50 ± 16.3 years, 70% female). Chart review revealed that 53 (15%) of these patients carried a…
  • Abstract Number: 52 • 2016 ACR/ARHP Annual Meeting

    Pregabalin Dose-Response for Sleep Quality and Pain Response in Fibromyalgia: A Post-Hoc Analysis of Three Randomized Trials

    Andrew Clair1, Ed Whalen1, Neal Thomas1 and Lynne Pauer2, 1Pfizer, New York, NY, 2Pfizer, Groton, CT

    Background/Purpose: Pregabalin is often administered for treatment of fibromyalgia (FM) at daily doses lower than approved by the US Food and Drug Administration (starting dose…
  • Abstract Number: 33 • 2016 ACR/ARHP Annual Meeting

    Prevalence of Growth Hormone Deficiency in Fibromyalgia Patients

    Thomas Romano, Private Practice, Martins Ferry, OH

    Background/Purpose: Low levels of Insulin-dependent growth factor 1 (IGF-1) have been described in Fibromyalgia (FM) patients, suggesting that they have adult growth hormone (GH) deficiency.…
  • Abstract Number: 2200 • 2016 ACR/ARHP Annual Meeting

    Association of Active Commuting and Physical Activity in Women with Fibromyalgia

    Manuel Herrador-Colmenero1, Fernando Estévez-López1, Víctor Segura-Jiménez1, Inmaculada C Álvarez-Gallardo1, Alberto Soriano-Maldonado1, Daniel Camiletti-Moirón1,2, Virginia A Aparicio1, Manuel Delgado-Fernández1 and Palma Chillón1, 1University of Granada, Granada, Spain, 2University of Cádiz, Cádiz, Spain

    Background/Purpose: Fibromyalgia symptomatology results in a low functional capacity1, limiting the daily activities and the quality of life of the patients2. Walking for commuting is…
  • Abstract Number: 54 • 2016 ACR/ARHP Annual Meeting

    Patients with Fibromyalgia in General Have Higher Self-Report Questionnaire Scores Than Patients with Rheumatoid Arthritis: Implications for Clinical Trials and Clinical Research

    Theodore Pincus1, Isabel Castrejón1, Joel Block2 and Nathaniel Cook1, 1Rheumatology, Rush University Medical Center, Chicago, IL, 2Division of Rheumatology, Rush University Medical Center, Chicago, IL

    Background/Purpose: Patients with rheumatoid arthritis (RA) who are included in clinical trials generally are selected for measures indicating high disease activity, such as more than…
  • « Previous Page
  • 1
  • …
  • 13
  • 14
  • 15
  • 16
  • 17
  • …
  • 25
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology